Is Broadcom a Buy After Its Latest Earnings Report?

04.06.26 00:40 Uhr

There was good and bad to be found in Broadcom's (NASDAQ: AVGO) second-quarter earnings report. On the one hand, revenue jumped 48% to $22.19 billion. And earnings of $2.44 per share were better than analysts' consensus expectations of $2.40 per share. However, Broadcom projected that artificial intelligence chip sales would reach $16 billion in the third quarter, below analysts' expectations of $17.2 billion. The company also maintained its full-year target of $100 billion in AI chip sales rather than raising it. That sent investors scrambling, and Broadcom stock fell more than 12% in after-hours trading today.Let's take a closer look at the report and what red flags the Street is seeing as Broadcom sells off following its Q2 earnings report.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

In eigener Sache

Übrigens: US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!

Quelle: MotleyFool

Nachrichten zu Broadcom Corp.

Analysen zu Broadcom Corp.

DatumRatingAnalyst
03.12.2015Broadcom HoldCanaccord Adams
20.08.2015Broadcom HoldArgus Research Company
03.08.2015Broadcom HoldCanaccord Adams
31.07.2015Broadcom Market PerformCowen and Company, LLC
31.07.2015Broadcom HoldTopeka Capital Markets
DatumRatingAnalyst
29.05.2015Broadcom BuyBrean Capital
28.05.2015Broadcom BuyArgus Research Company
22.04.2015Broadcom OutperformRBC Capital Markets
22.04.2015Broadcom BuyTopeka Capital Markets
22.04.2015Broadcom BuyBrean Capital
DatumRatingAnalyst
03.12.2015Broadcom HoldCanaccord Adams
20.08.2015Broadcom HoldArgus Research Company
03.08.2015Broadcom HoldCanaccord Adams
31.07.2015Broadcom Market PerformCowen and Company, LLC
31.07.2015Broadcom HoldTopeka Capital Markets
DatumRatingAnalyst
22.07.2013Broadcom verkaufenExane-BNP Paribas SA
11.04.2013Broadcom verkaufenBarclays Capital
26.03.2013Broadcom verkaufenExane-BNP Paribas SA
12.11.2012Broadcom underperformExane-BNP Paribas SA
18.10.2012Broadcom underperformExane-BNP Paribas SA

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Broadcom Corp. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen